Respiratory Complex III NQ-Site Ligands for Selective ROS Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for new compounds that can modulate reactive oxygen species (ROS) production to understand and treat various disorders, including cancer, musculoskeletal disorders, and neurodegenerative diseases, as existing strategies lack effective modulation of ROS levels at the respiratory complex III.
Innovation Solution
Compounds are designed to bind preferentially at the NQ-binding site of respiratory complex III, modulating ROS levels by altering the conformation of the Phe90 residue, thereby controlling electron transfer between heme bL and heme bH redox pairs, leading to either elevated or reduced ROS production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If compounds bind at the Qo or Qi sites of respiratory complex III, then electron transfer can be modulated, but the ability to selectively control ROS production is limited
Solution Approach 1:
The patent introduces a novel NQ-binding site distinct from the conventional Qo and Qi sites. This local differentiation allows compounds to exert specific effects on electron transfer pathways - particularly on the low-potential arm involving heme bL and heme bH - enabling selective ROS modulation without interfering with other mitochondrial functions. The localized binding site provides spatial specificity that enhances both adaptability and reliability of ROS control.
Solution Approach 2:
The Phe90 residue serves as a conformational intermediary that transmits the effect of NQ-site ligand binding to the electron transfer pathway. When compounds bind at the NQ-site, they induce conformational changes in Phe90, which in turn modulates electron transfer between heme bL and heme bH. This intermediary mechanism provides a controlled, reliable pathway for ROS modulation that can be selectively activated or inhibited.
2Reliability
If existing strategies are used to modulate ROS levels, then some disease treatment is possible, but effective modulation at respiratory complex III is lacking
Solution Approach 1:
The NQ-binding site compounds demonstrate multi-functionality by being able to both increase and decrease ROS production depending on the specific compound and cellular context. This universal capability allows the same binding site to address diverse disease conditions - either by suppressing excessive ROS in neurodegenerative diseases or by enhancing ROS to trigger apoptosis in cancer cells. The compounds can selectively target unhealthy cells while sparing healthy cells, providing versatile therapeutic application across multiple disease types.
3Productivity
If ROS levels are elevated to treat cancer, then apoptosis in cancer cells is triggered, but normal cells may be damaged
Solution Approach 1:
The NQ-site compounds exhibit local quality by selectively targeting mitochondrial electron transfer pathways in a context-dependent manner. In cancer cells, the compounds can be designed to accumulate and induce high ROS production that triggers apoptosis. In normal cells, the same compounds either do not accumulate to the same extent or induce milder ROS changes that remain within physiological ranges. This spatial and cellular selectivity allows potent anticancer effects while protecting normal cells from damage.
Solution Approach 2:
The therapeutic strategy employs partial action by modulating ROS production to different extents in different cell types. In cancer cells, the compounds induce excessive ROS production that exceeds the apoptotic threshold, triggering cell death. In normal cells, the ROS modulation remains partial and controlled, staying below the apoptotic threshold and maintaining cellular function. This differential dosing effect enables selective cancer cell killing without harming normal tissues.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These compounds provide a broader range of ROS modulation, enabling effective treatment or prevention of diseases such as cancer, rheumatoid arthritis, osteoarthritis, Alzheimer's, Parkinson's, and other disorders by selectively increasing or decreasing ROS levels in healthy or unhealthy cells.
Implementation Method 1
controlling electron transfer between heme bL and heme bH redox pairs
Implementation Method 2
heme bL and heme bH redox pairs
Implementation Method 3
ROS are generated naturally by multiple enzymes, including respiratory complexes such as respiratory complex III... during the oxidative phosphorylation process
Implementation Method 4
Reactive oxygen species (ROS) are by-products of normal cellular aerobic metabolism
Data Source
AI summary
In some aspects, the present disclosure provides methods for modulating the level of reactive oxygen species. In some embodiments, the present methods involve the use of compounds that bind to respiratory complex III at the NQ-binding site. The present methods may be used for treatment or prevention of a disease or disorder, for example a disease or disorder characterized by or associated with dysregulated levels of reactive oxygen species.